Michael Injaychock
About Michael Injaychock
Michael Injaychock is the Executive Director of US CAR-T Commercialization at Bristol-Myers Squibb in Chicago, Illinois, with a background in marketing and analytics in the pharmaceutical industry.
Title
Michael Injaychock currently holds the position of Executive Director, US CAR-T Commercialization at Bristol-Myers Squibb. He is based in Chicago, Illinois, United States.
Previous Roles at Celgene
From 2017 to 2019, Michael Injaychock worked at Celgene as the Executive Director of Data and Analytics in the Hematology/Oncology department. During his tenure in Summit, New Jersey, he was tasked with managing the application of data analytics in the field of hematology and oncology.
Career at Eli Lilly and Company
Michael Injaychock has an extensive career at Eli Lilly and Company, where he held several senior positions over a decade. From 2015 to 2017, he served as the Senior Director of Global Marketing, focusing on Oncology, Diabetes, and Biomedicine in the Indianapolis, Indiana, and Lebanon, Indiana areas. Prior to that, he was Head of Marketing Research, Analytics & Channel Innovation for the Japan Affiliate from 2012 to 2015 in Kobe, Hyogo, Japan. He also held positions such as Brand Leader for Humulin and Diabetes Long Term Care (2010-2012) and participated in the Lilly Leadership Development Program (2007-2010).
Former Role at CEB, Now Gartner
Michael Injaychock was associated with CEB, now known as Gartner, from 2000 to 2005. He worked as an Associate Director in the Retail Financial Services Division. His responsibilities involved maximizing client and vendor relationships through effective management practices.
Education and Expertise
Michael Injaychock holds a Master of Business Administration (MBA) from UNC Kenan-Flagler Business School, completed between 2005 and 2007. He also earned a Bachelor of Arts (B.A.) from William & Mary from 1996 to 2000. Additionally, he achieved an Advanced Certificate for Executives in Management, Innovation and Technology (ACE) from the Massachusetts Institute of Technology - Sloan School of Management.
Strategic Commercialization Efforts
At Bristol-Myers Squibb, Michael Injaychock leads the US strategic commercialization efforts for the CAR T/Cell Therapy platform. His focus is on delivering best-in-class launches in Diffuse Large B-Cell Lymphoma (DLBCL) and Multiple Myeloma. His role involves merging marketing and technology to drive commercial operations and brand management effectively.
Background in International Business
Michael Injaychock has a strong international business background. Notably, he served as Head of Marketing Research, Analytics & Channel Innovation for Eli Lilly and Company's Japan Affiliate in Kobe, Hyogo, from 2012 to 2015. This position required him to navigate the complexities of the Japanese market and drive business objectives through commercial analytics management.
Organizational Change Agent
Known for being an organizational change agent, Michael Injaychock has successfully led both revenue-generating and capability-building roles throughout his career. His leadership style is characterized by fostering team engagement to enhance strategic vision and execution competency. His expertise lies in leveraging customer insights to drive business objectives.